Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier.
Saved in:
| Title: | Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier. |
|---|---|
| Authors: | Puchongmart C; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Rodriguez CC; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Soliman D; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Shotelersuk V; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Sivakumar N; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Yanpiset P; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Thiravetyan B; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Leelaviwat N; Division of Cardiovascular Disease, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Sly Z; Division of Cardiovascular Disease, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX. |
| Source: | Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2026 Jul 06. Date of Electronic Publication: 2026 Jul 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7902492 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4023 (Electronic) Linking ISSN: 01602446 NLM ISO Abbreviation: J Cardiovasc Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
